These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32989254)

  • 1. Ephrin-B2-EphB4 communication mediates tumor-endothelial cell interactions during hematogenous spread to spinal bone in a melanoma metastasis model.
    Broggini T; Piffko A; Hoffmann CJ; Ghori A; Harms C; Adams RH; Vajkoczy P; Czabanka M
    Oncogene; 2020 Nov; 39(47):7063-7075. PubMed ID: 32989254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2-EphB4 Signaling in Melanoma Metastatic Spine Disease.
    Piffko A; Broggini T; Harms C; Adams RH; Vajkoczy P; Czabanka M
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.
    Pfaff D; Héroult M; Riedel M; Reiss Y; Kirmse R; Ludwig T; Korff T; Hecker M; Augustin HG
    J Cell Sci; 2008 Nov; 121(Pt 22):3842-50. PubMed ID: 18957513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2.
    Héroult M; Schaffner F; Pfaff D; Prahst C; Kirmse R; Kutschera S; Riedel M; Ludwig T; Vajkoczy P; Graeser R; Augustin HG
    Mol Cancer Res; 2010 Oct; 8(10):1297-309. PubMed ID: 21047731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.
    Nguyen TM; Arthur A; Hayball JD; Gronthos S
    Stem Cells Dev; 2013 Oct; 22(20):2751-64. PubMed ID: 23711177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation.
    Wang Y; Menendez A; Fong C; ElAlieh HZ; Chang W; Bikle DD
    J Bone Miner Res; 2014 Aug; 29(8):1900-13. PubMed ID: 24677183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sinusoidal ephrin receptor EPHB4 controls hematopoietic progenitor cell mobilization from bone marrow.
    Kwak H; Salvucci O; Weigert R; Martinez-Torrecuadrada JL; Henkemeyer M; Poulos MG; Butler JM; Tosato G
    J Clin Invest; 2016 Dec; 126(12):4554-4568. PubMed ID: 27820703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells.
    Hamada K; Oike Y; Ito Y; Maekawa H; Miyata K; Shimomura T; Suda T
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):190-7. PubMed ID: 12588758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells.
    Foubert P; Silvestre JS; Souttou B; Barateau V; Martin C; Ebrahimian TG; Leré-Déan C; Contreres JO; Sulpice E; Levy BI; Plouët J; Tobelem G; Le Ricousse-Roussanne S
    J Clin Invest; 2007 Jun; 117(6):1527-37. PubMed ID: 17510705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity.
    Noberini R; Mitra S; Salvucci O; Valencia F; Duggineni S; Prigozhina N; Wei K; Tosato G; Huang Z; Pasquale EB
    PLoS One; 2011; 6(12):e28611. PubMed ID: 22194865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis.
    Martiny-Baron G; Holzer P; Billy E; Schnell C; Brueggen J; Ferretti M; Schmiedeberg N; Wood JM; Furet P; Imbach P
    Angiogenesis; 2010 Sep; 13(3):259-67. PubMed ID: 20803239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
    Füller T; Korff T; Kilian A; Dandekar G; Augustin HG
    J Cell Sci; 2003 Jun; 116(Pt 12):2461-70. PubMed ID: 12734395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EphB4 receptor-tyrosine kinase promotes the migration of melanoma cells through Rho-mediated actin cytoskeleton reorganization.
    Yang NY; Pasquale EB; Owen LB; Ethell IM
    J Biol Chem; 2006 Oct; 281(43):32574-86. PubMed ID: 16950769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts.
    Kwan Tat S; Pelletier JP; Amiable N; Boileau C; Lajeunesse D; Duval N; Martel-Pelletier J
    Arthritis Rheum; 2008 Dec; 58(12):3820-30. PubMed ID: 19035475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
    Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ephrin-B stimulation of calvarial bone formation.
    Benson MD; Opperman LA; Westerlund J; Fernandez CR; San Miguel S; Henkemeyer M; Chenaux G
    Dev Dyn; 2012 Dec; 241(12):1901-10. PubMed ID: 23129351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and Characterization of Ephrin B2 and EphB4 Dysregulation and Novel Mutations in Cerebral Cavernous Malformations: In Vitro and Patient-Derived Evidence of Ephrin-Mediated Endothelial Cell Pathophysiology.
    Sesen J; Ghalali A; Driscoll J; Martinez T; Lupieri A; Zurakowski D; Alexandrescu S; Smith ER; Fehnel KP
    Cell Mol Neurobiol; 2023 Dec; 44(1):12. PubMed ID: 38150042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers.
    Bhatia S; Oweida A; Lennon S; Darragh LB; Milner D; Phan AV; Mueller AC; Van Court B; Raben D; Serkova NJ; Wang XJ; Jimeno A; Clambey ET; Pasquale EB; Karam SD
    Cancer Res; 2019 May; 79(10):2722-2735. PubMed ID: 30894369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
    Bai J; Wang YJ; Liu L; Zhao YL
    J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand.
    Rutkowski R; Mertens-Walker I; Lisle JE; Herington AC; Stephenson SA
    Int J Cancer; 2012 Sep; 131(5):E614-24. PubMed ID: 22161689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.